Charge variants characterization and release assay development for co-formulated antibodies as a combination therapy

Combination therapy is a fast-growing strategy to maximize therapeutic benefits to patients. Co-formulation of two or more therapeutic proteins has advantages over the administration of multiple medications, including reduced medication errors and convenience for patients. Characterization of co-for...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Mingyan, De Mel, Niluka, Shannon, Anthony, Prophet, Meagan, Wang, Chunlei, Xu, Weichen, Niu, Ben, Kim, Jun, Albarghouthi, Methal, Liu, Dengfeng, Meinke, Eric, Lin, Shihua, Wang, Xiangyang, Wang, Jihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512943/
https://www.ncbi.nlm.nih.gov/pubmed/30786796
http://dx.doi.org/10.1080/19420862.2019.1578137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512943/
https://www.ncbi.nlm.nih.gov/pubmed/30786796
http://dx.doi.org/10.1080/19420862.2019.1578137

Ejemplares similares